http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008066402-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ec120b0d8fcb326ac36223123cb0d26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_601c1203d074153e89f4858f93e5cb66
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2006-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66729b1b4073e87d9e3cd9f5c391904e
publicationDate 2008-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008066402-A1
titleOfInvention Use of malachite green in the form of drug for treating malignant neoplasms
abstract The invention relates to the use of malachite green in the form of a tetramethyldiamino-triphenyl-carbinol anhydro-oxalate [(C23H25N2)-(C2HO4)]2-C2H2O4 of the following structural formula (I) as a drug for treating malignant neoplasms administered in a single doze of 1 to 2 g. Malachite green can be used when dissolved in an aqueous solution or in a physiological salt solution or in spirit. In different cases the malachite green solution is perorally administered before and after meal or is injected per rectum, or a 1% malachite green solution is intravenously introduced, or the malachite green is applied as a rectal suppository component or as a component of 1-5% ointment. Said medicinal agent exhibits an extended range of therapeutic actions with respect to different oncological diseases, is freely available, not expensive, non-toxic, does not generate side effects when used in pharmaceutically acceptable doses, makes it possible to reduce a treating time and to increase the efficiency of treatment.
priorityDate 2006-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2084604-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87769457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87769903
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230917934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230919841

Total number of triples: 23.